Abstract:Germline mutations in RASA1 are associated with capillary malformation-arteriovenous malformation (CM-AVM) syndrome. CM-AVM syndrome is characterized by multi-focal capillary malformations and arteriovenous malformations. Lymphatic anomalies have been proposed as part of the phenotype. Intrafamilial variability has been reported, suggesting modifiers and somatic events. The objective of the study was to identify somatic RASA1 "second hits" from vascular malformations associated with CM-AVM syndrome, and describe phenotypic variability. Participants were examined and phenotyped. Genomic DNA was extracted from peripheral blood on all participants. Whole-exome sequencing was performed on the proband. Using Sanger sequencing, RASA1 exon 8 was PCR-amplified to track the c.1248T>G, p.Tyr416X germline variant through the family. A skin biopsy of a capillary malformation from the proband's mother was also obtained, and next-generation sequencing was performed on DNA from the affected tissue. A familial germline heterozygous novel pathogenic RASA1 variant, c.1248T>G (p.Tyr416X), was identified in the proband and her mother. The proband had capillary malformations, chylothorax, lymphedema, and overgrowth, while her affected mother had only isolated capillary malformations. Sequence analysis of DNA extracted from a skin biopsy of a capillary malformation of the affected mother showed a second RASA1 somatic mutation (c.2245C>T, p.Arg749X). These results and the extreme variable expressivity support the hypothesis that somatic "second hits" are required for the development of vascular anomalies associated with CM-AVM syndrome. In addition, the phenotypes of the affected individuals further clarify that lymphatic manifestations are also part of the phenotypic spectrum of RASA1-related disorders. © 2016 Wiley Periodicals, Inc.

5q14.3 neurocutaneous syndrome: A novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C

5q14.3 Microdeletion Syndrome With Simultaneous Involvement of MEF2C and RASA1. Clinical Case and Review of the Literature

The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome

Microdeletion 5q14.3 and anomalies of brain development

De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum

Duplication of C7orf58, WNT16 and FAM3C in an Obese Female with a T(7;22)(q32.1;q11.2) Chromosomal Translocation and Clinical Features Resembling Coffin-Siris Syndrome

Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature?

Phenotypic and Molecular Convergence of 2q23.1 Deletion Syndrome with Other Neurodevelopmental Syndromes Associated with Autism Spectrum Disorder

Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy?

MEF2C-Related 5q14.3 Microdeletion Syndrome Detected by Array CGH: A Case Report

RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome

Severe manifestation of Rauch‐Azzarello syndrome associated with biallelic deletion of CTNND2

Congenital melanocytic nevus syndrome: An association between congenital melanocytic nevi and neurological abnormalities

MEF2C deletions and mutations versus duplications: a clinical comparison

Bi-allelic CAMSAP1 variants cause a clinically recognizable neuronal migration disorder

A Novel 1p33p32.2 Deletion Involving SCP2, ORC1, and DAB1 Genes in a Patient with Craniofacial Dysplasia, Short Stature, Developmental Delay, and Leukoencephalopathy

Novel postzygotic RASA1 mutation in a patient with Parkes Weber syndrome: A case report and literature review

Two neighboring microdeletions of 5q13.2 in a child with oculo-auriculo-vertebral spectrum.

Another face of RASA1: Report of familial germline variant in RASA1 with dysmorphic features

Myoclonus dystonia plus syndrome due to a novel 7q21 microdeletion

Phenotypic and molecular characterization of 19q12q13.1 deletions: A report of five patients